Name | Value |
---|---|
Revenues | 17.4M |
Cost of Revenue | 7.8M |
Gross Profit | 9.6M |
Operating Expense | 56.6M |
Operating I/L | -50.1M |
Other Income/Expense | -9.2M |
Interest Income | 0.7M |
Pretax | -59.3M |
Income Tax Expense | -28.9M |
Net Income/Loss | -24.8M |
Fortress Biotech, Inc. is a biopharmaceutical company that develops and commercializes pharmaceutical and biotechnology products. The company's revenue is generated through the marketing of dermatology products for conditions such as acne, ringworm, dry skin, and wound management. Additionally, it focuses on late-stage product candidates for various medical conditions including pain management, genetic diseases, cancer, and infectious diseases. The company also has a pipeline of early-stage and preclinical product candidates for diseases such as cancer, neurological disorders, and genetic conditions. Fortress Biotech, Inc. collaborates with universities, research institutes, and pharmaceutical companies to advance its product portfolio.